Stuart Hogarth

1.1k total citations
28 papers, 563 citations indexed

About

Stuart Hogarth is a scholar working on Public Health, Environmental and Occupational Health, Physiology and Economics and Econometrics. According to data from OpenAlex, Stuart Hogarth has authored 28 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 11 papers in Physiology and 7 papers in Economics and Econometrics. Recurrent topics in Stuart Hogarth's work include Biomedical Ethics and Regulation (10 papers), Biotechnology and Related Fields (8 papers) and BRCA gene mutations in cancer (6 papers). Stuart Hogarth is often cited by papers focused on Biomedical Ethics and Regulation (10 papers), Biotechnology and Related Fields (8 papers) and BRCA gene mutations in cancer (6 papers). Stuart Hogarth collaborates with scholars based in United Kingdom, Canada and United States. Stuart Hogarth's co-authors include David Melzer, Gail Javitt, Paula Saukko, Michael M. Hopkins, Matthew Reed, Nicky Britten, Karen Lock, Martin Gorsky, Brian Salter and Ron Zimmern and has published in prestigious journals such as Nature Biotechnology, PLoS ONE and Nature Reviews Genetics.

In The Last Decade

Stuart Hogarth

26 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart Hogarth United Kingdom	12	258	178	118	73	71	28	563
Gail Javitt United States	15	548 2.1×	280 1.6×	177 1.5×	130 1.8×	56 0.8×	34	927
Anya E. R. Prince United States	15	310 1.2×	207 1.2×	82 0.7×	82 1.1×	74 1.0×	53	644
Bartha Maria Knoppers Canada	14	162 0.6×	268 1.5×	159 1.3×	124 1.7×	54 0.8×	25	646
Deanna Alexis Carere United States	15	490 1.9×	265 1.5×	103 0.9×	74 1.0×	41 0.6×	21	641
Drc Chalmers Australia	14	123 0.5×	366 2.1×	217 1.8×	105 1.4×	97 1.4×	73	691
Alice K. Hawkins Canada	10	112 0.4×	275 1.5×	149 1.3×	79 1.1×	96 1.4×	11	454
Emilia Niemiec Sweden	15	181 0.7×	214 1.2×	79 0.7×	162 2.2×	52 0.7×	22	543
Juli Bollinger United States	16	426 1.7×	505 2.8×	207 1.8×	89 1.2×	172 2.4×	50	910
Pascale Bourret France	11	224 0.9×	168 0.9×	105 0.9×	89 1.2×	56 0.8×	31	505
Laura Lyman Rodriguez United States	14	275 1.1×	440 2.5×	191 1.6×	129 1.8×	171 2.4×	24	797

Countries citing papers authored by Stuart Hogarth

Since Specialization

Citations

This map shows the geographic impact of Stuart Hogarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Hogarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Hogarth more than expected).

Fields of papers citing papers by Stuart Hogarth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Hogarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Hogarth. The network helps show where Stuart Hogarth may publish in the future.

Co-authorship network of co-authors of Stuart Hogarth

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Hogarth. A scholar is included among the top collaborators of Stuart Hogarth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Hogarth. Stuart Hogarth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sullivan, Richard J., et al.. (2025). Media coverage and PATHFINDER2: hype, simplification, and free advertising. The Lancet Oncology. 27(2). 144–145.

Hogarth, Stuart, et al.. (2025). Prognosis, treatment decision-making and value: A qualitative exploration of the emerging role of breast cancer prognostic assays. PLoS ONE. 20(7). e0322509–e0322509.

Hunter, Sarah C., et al.. (2023). Industry involvement in evidence production for genomic medicine: A bibliometric and funding analysis of decision impact studies. PLoS ONE. 18(4). e0285122–e0285122. 7 indexed citations

Hogarth, Stuart & Olga Löblová. (2020). Regulatory niches: Diagnostic reform as a process of fragmented expansion. Evidence from the UK 1990–2018. Social Science & Medicine. 304. 113363–113363. 1 indexed citations

Liddicoat, John, Kathleen Liddell, Stuart Hogarth, et al.. (2019). Continental drift? Do European clinical genetic testing laboratories have a patent problem?. European Journal of Human Genetics. 27(7). 997–1007. 6 indexed citations

Holloway, Kelly, et al.. (2019). Health Canada needs to act on laboratory-developed diagnostics. Canadian Medical Association Journal. 191(39). E1067–E1069. 6 indexed citations

Holloway, Kelly, et al.. (2019). Dangerous diagnostics? Regulatory reform in the genomic era. BMJ. 364. l640–l640. 8 indexed citations

Hogarth, Stuart & Paula Saukko. (2017). A market in the making: the past, present and future of direct-to-consumer genomics. New Genetics and Society. 36(3). 197–208. 32 indexed citations

Hogarth, Stuart, Michael M. Hopkins, & Daniele Rotolo. (2015). Technological Accretion in Diagnostics: HPV Testing and Cytology in Cervical Cancer Screening. Europe PMC (PubMed Central). 3 indexed citations

10.

Hogarth, Stuart. (2015). Neoliberal technocracy: Explaining how and why the US Food and Drug Administration has championed pharmacogenomics. Social Science & Medicine. 131. 255–262. 14 indexed citations

11.

Gorsky, Martin, Karen Lock, & Stuart Hogarth. (2014). Public health and English local government: historical perspectives on the impact of 'returning home'. Journal of Public Health. 36(4). 546–551. 29 indexed citations

12.

Dar, Osman, Maya Gobin, Stuart Hogarth, Chris Lane, & Mary Ramsay. (2013). Mapping the Gypsy Traveller community in England: what we know about their health service provision and childhood immunization uptake. Journal of Public Health. 35(3). 404–412. 23 indexed citations

13.

Hopkins, Michael M. & Stuart Hogarth. (2012). Biomarker patents for diagnostics: problem or solution?. Nature Biotechnology. 30(6). 498–500. 9 indexed citations

14.

Frueh, Felix W., et al.. (2011). The future of direct-to-consumer clinical genetic tests. Nature Reviews Genetics. 12(7). 511–515. 34 indexed citations

15.

Hogarth, Stuart, et al.. (2011). A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA. Sociology of Health & Illness. 34(2). 234–250. 32 indexed citations

16.

Hogarth, Stuart. (2010). Myths, Misconceptions and Myopia: Searching for Clarity in the Debate about the Regulation of Consumer Genetics. Public Health Genomics. 13(5). 322–326. 11 indexed citations

17.

Saukko, Paula, Matthew Reed, Nicky Britten, & Stuart Hogarth. (2009). Negotiating the boundary between medicine and consumer culture: Online marketing of nutrigenetic tests. Social Science & Medicine. 70(5). 744–753. 45 indexed citations

18.

Melzer, David, et al.. (2008). Genetic tests for common diseases: new insights, old concerns. BMJ. 336(7644). 590–593. 36 indexed citations

19.

Hogarth, Stuart, Gail Javitt, & David Melzer. (2008). The Current Landscape for Direct-to-Consumer Genetic Testing: Legal, Ethical, and Policy Issues. Annual Review of Genomics and Human Genetics. 9(1). 161–182. 192 indexed citations

20.

Liddell, Kathleen, Stuart Hogarth, David Melzer, & Ron Zimmern. (2008). Patents as incentives for translational and evaluative research: the case of genetic tests and their improved clinical performance. Research Portal (King's College London). 286–327. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact